At Yarrow, we are driven by the spirit of innovation and the quest for excellence.
We are committed to advancing safe and effective biological discoveries, bridging the gap between cutting-edge research and real-world solutions, and bringing hope to those who need it most.
Our lead program is for the treatment of autoimmune disease with the potential to be the first- and best-in-class disease-modifying therapy in multiple indications.
The name Yarrow is inspired by the ancient history of the yarrow plant, Achillea millefolium, named after the Greek hero Achilles. According to myth, Achilles used the yarrow plant to treat his warriors' wounds during the Trojan War, symbolizing healing, strength, and resilience.
At Yarrow Biotechnology, we believe in the power of teamwork and collaboration. Our journey, like that of Achilles and his warriors, is about combining the strengths and contributions of each team member to achieve the seemingly impossible. Together, we are on a mission to create transformative medicines and deliver life-changing solutions to patients worldwide.
We are dedicated to developing groundbreaking biologic solutions for inflammatory and cardiometabolic diseases that improve lives.
Autoimmune disorders affect 1 in 10 Americans, making it the third most prevalent disease category after cancer and heart disease. With more than 80 autoimmune diseases identified, diagnosis can be difficult and treatments not yet available to ease symptoms. Women make up almost 80% of individuals suffering from a chronic autoimmune condition.
Yarrow was founded and incubated by RTW and is rooted in the firm’s longstanding expertise and commitment to power breakthrough therapies that transform the lives of patients.
By working closely with the RTW Team, we are committed to strengthening our internal R&D capabilities by launching innovative drug discovery programs and in-licensing strategic assets, enabling us to make a greater impact on patient's lives.
Pipeline
Scientifically driven by our scientists and a strong, long-term financial commitment from our founders at RTW. Our targets and approaches stem from knowledge and breakthroughs in human biology, pharmacology and genetics. We are fueled by a sense of urgency and a dedication to scientific rigor.
